Effects of amyloid β-peptides on the lysis tension of lipid bilayer vesicles containing oxysterols

Biophysical Journal

Volumn 95, Issue 2, 2008, Pages 620-628

  Kim, Dennis H ^a   Frangos, John A ^a  

^a LA JOLLA BIOENGINEERING INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; LIPOSOME; PHOSPHOLIPID; STEROL;

ARTICLE; CELL FRACTIONATION; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; LIPID BILAYER; MEMBRANE FLUIDITY; SURFACE TENSION;

AMYLOID BETA-PROTEIN; CELL FRACTIONATION; COMPUTER SIMULATION; LIPID BILAYERS; LIPOSOMES; MEMBRANE FLUIDITY; MODELS, CHEMICAL; MODELS, MOLECULAR; PHOSPHOLIPIDS; STEROLS; SURFACE TENSION;

EID: 47749155975     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1529/biophysj.107.114983     Document Type: Article

References (67)

1. Hardy, J. A., and G. A. Higgins. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:184-185.
2. Lorenzo, A., and B. A. Yankner. 1994. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA. 91:12243-12247.
3. Behl, C., J. B. Davis, R. Lesley, and D. Schubert. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:817-827.
4. Huang, X., C. S. Atwood, M. A. Hartshorn, G. Multhaup, L. E. Goldstein, R. C. Scarpa, M. P. Cuajungco, D. N. Gray, J. Lim, R. D. Moir, R. E. Tanzi, and A. I. Bush. 1999. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38:7609-7616.
5. Praprotnik, D., M. A. Smith, P. L. Richey, H. V. Vinters, and G. Perry. 1996. Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress. Acta Neuropathol. (Berl.). 91:1-5.
6. Akama, K. T., C. Albanese, R. G. Pestell, and L. J. Van Eldik. 1998. Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism. Proc. Natl. Acad. Sci. USA. 95:5795-5800.
7. Keil, U., A. Bonert, C. A. Marques, I. Scherping, J. Weyermann, J. B. Strosznajder, F. Müller-Spahn, C. Haass, C. Czech, L. Pradier, W. E. Müller, and A. Eckert. 2004. Amyloid β-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J. Biol. Chem. 279:50310-50320.
8. Yan, S. D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Mighelli, P. Nawroth, D. Stern, and A. M. Schmidt. 1996. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:685-691.
9. Giri, R., Y. Shen, M. Stins, S. D. Yan, A. M. Schmidt, D. Stern, K.-S. Kim, B. Zlokovic, and V. K. Kalra. 2000. β-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. Cell Physiol. 279:1772-1781.
10. Arispe, N., H. B. Pollard, and E. Rojas. 1993. Giant multilevel cation channels formed by Alzheimer's disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. USA. 90:10573-10577.
11. Arispe, N., E. Rojas, and H. B. Pollard. 1993. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA. 90:567-571.
12. Mirzabekov, T., M. Lin, W. Yuan, P. J. Marshall, M. Carman, K. Tomaselli, I. Lieberburg, and B. L. Kagan. 1994. Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide. Biochem. Biophys. Res. Commun. 202:1142-1148.
13. Hirakura, Y., M.-C. Lin, and B. L. Kagan. 1999. Alzheimer amyloid Aβ1-42 channels: effects of solvent, pH, and Congo red. J. Neurosci. Res. 57:458-466.
14. Arispe, N. 2004. Architecture of the Alzheimer's AβP ion channel pore. J. Membr. Biol. 197:33-48.
15. Behl, C., J. B. Davis, G. F. Klier, and D. Schubert. 1994. Amyloid b peptide induces necrosis rather than apoptosis. Brain Res. 645:253-264.
16. Paradis, E., H. Douillard, M. Koutroumanis, C. Goodyer, and A. LeBlanc. 1996. Amyloid β peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J. Neurosci. 16:7533-7539.
17. Kajkowski, E. M., C. F. Lo, X. Ning, S. Walker, H. J. Sofia, W. Wang, W. Edris, P. Chanda, E. Wagner, S. Vile, K. Ryan, B. McHendry-Rinde, S. C. Smith, A. Wood, K. J. Rhodes, J. D. Kennedy, J. Bard, J. S. Jacobsen, and B. A. Ozenberger. 2001. β-amyloid peptide-induced apoptosis regulated by a novel protein containing a G protein activation module. J. Biol. Chem. 276:18748-18756.
18. Kayed, R., Y. Sokolov, B. Edmonds, T. M. McIntire, S. C. Milton, J. E. Hall, and C. G. Glabe. 2004. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279:46363-46366.
19. Ambroggio, E. E., D. H. Kim, F. Separovic, C. J. Barrow, K. J. Barnham, L. A. Bagatolli, and G. D. Fidelio. 2005. Surface behavior and lipid interaction of Alzheimer β-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys. J. 88:2706-2713.
20. Zhelev, D. V., N. Stoicheva, P. Scherrer, and D. Needham. 2001. Interaction of synthetic HA2 influenza fusion peptide analog with model membranes. Biophys. J. 81:285-304.
21. Terzi, E., and G. Hölzemann. 1997. Interaction of Alzheimer β-amyloid peptide(1-40) with lipid membranes. Biochemistry. 36:14845-14852.
22. McLaurin, J., and A. Chakrabartty. 1996. Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. J. Biol. Chem. 271:26482-26489.
23. McLaurin, J., T. Franklin, P. E. Fraser, and A. Chakrabartty. 1998. Structural transitions associated with the interaction of Alzheimer β-amyloid peptides with gangliosides. J. Biol. Chem. 273:4506-4515.
24. Yip, C. M., and J. McLaurin. 2001. Amyloid-β peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys. J. 80:1359-1371.
25. Kakio, A., S. Nishimoto, K. Yanagisawa, Y. Kozutsumi, and K. Matsuzaki. 2001. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276:24985-24990.
26. Kremer, J. J., M. M. Pallitto, D. J. Sklansky, and R. M. Murphy. 2000. Correlation of β-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry. 39:10309-10318.
27. Kremer, J. J., D. J. Sklansky, and R. M. Murphy. 2001. Profile of changes in lipid bilayer structure caused by β-amyloid peptide. Biochemistry. 40:8563-8571.
28. Curtain, C. C., F. E. Ali, D. G. Smith, A. I. Bush, C. L. Masters, and K. J. Barnham. 2003. Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-β peptide with membrane lipid. J. Biol. Chem. 278:2977-2982.
29. Pike, C. J., D. Burdick, A. J. Walencewicz, C. G. Glabe, and C. W. Cotman. 1993. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1676-1687.
30. Dahlgren, K. N., A. M. Manelli, W. B. Stine, Jr., L. K. Baker, G. A. Krafft, and M. J. LaDu. 2002. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277:32046-32053.
31. Stine, W. B., Jr., K. N. Dahlgren, G. A. Krafft, and M. J. LaDu. 2003. In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278:11612-11622.
32. Lang, J. K. 1990. Quantitative determination of cholesterol in liposome drug products and raw materials by high-performance liquid chromatography. J. Chromatogr. 507:157-163.
33. Angelova, M. I., and D. S. Dimitrov. 1986. Liposome electroformation. Faraday Disc. Chem. Soc. 81:303-311.
34. Angelova, M. I., S. Soleau, P. Meleard, J. F. Faucon, and P. Bothorel. 1992. Preparation of giant vesicles by external AC electric fields. Kinetics and applications. Prog. Colloid Polym. Sci. 89:127-131.
35. Evans, E., and D. Needham. 1987. Physical properties of surfactant bilayer membranes: thermal transitions, elasticity, rigidity, cohesion, and colloidal interactions. J. Phys. Chem. 91:4219-4228.
36. Needham, D., and D. V. Zhelev. 1996. The mechanochemistry of lipid vesicles examined by micropipet manipulation techniques. In Vesicles. M. Rosoff, editor. Marcel Dekker, New York. 373-444.
37. Meltzer, H., and A. Silberberg. 1988. Adsorption of collagen, serum albumin, and fibronectin to glass and to each other. J. Colloid Interface Sci. 126:292-303.
38. Rand, R. P., and A. C. Burton. 1964. Mechanical properties of the red cell membrane. I. Membrane Stiffness and Intracellular Pressure. Biophys. J. 4:115-135.
39. Evans, E. A., R. Waugh, and L. Melnik. 1976. Elastic area compressibility modulus of red cell membrane. Biophys. J. 16:585-595.
40. Evans, E., V. Heinrich, F. Ludwig, and W. Rawicz. 2003. Dynamic tension spectroscopy and strength of biomembranes. Biophys. J. 85:2342-2350.
41. Evans, E. A., and R. Skalak. 1980. Mechanics and Thermodynamics of Biomembranes. CRC Press, Boca Raton, FL.
42. Kim, D. H., and D. Needham. 2002. Lipid bilayers and monolayers: characterization using micropipette manipulation techniques. In Encyclopedia of Surface and Colloid Science. A. T. Hubbard, editor. Marcel Dekker, New York. 3057-3086.
43. Theunissen, J. J. H., R. L. Jackson, H. J. M. Kempen, and R. A. Demel. 1986. Membrane properties of oxysterols. Interfacial orientation, influence on membrane permeability and redistribution between membranes. Biochim. Biophys. Acta. 860:66-74.
44. Smith, L. L. 1987. Cholesterol autoxidation 1981-1986. Chem. Phys. Lipids. 44:87-125.
45. Needham, D., and R. S. Nunn. 1990. Elastic deformation and failure of lipid bilayer membranes containing cholesterol. Biophys. J. 58:997-1009.
46. Wood, W. G., F. Schroeder, U. Igbavboa, N. A. Avdulov, and S. V. Chochina. 2002. Brain membrane cholesterol domains, aging and amyloid beta-peptides. Neurobiol. Aging. 23:685-694.
47. Calderon, R. O., B. Attema, and G. H. DeVries. 1995. Lipid composition of neuronal cell bodies and neurites from cultured dorsal root ganglia. J. Neurochem. 64:424-429.
48. Björkhem, I., and S. Meaney. 2004. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24:806-815.
49. Hensley, K., J. M. Carney, M. P. Mattson, M. Aksenova, M. Harris, J. F. Wu, R. A. Floyd, and D. A. Butterfield. 1994. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:3270-3274.
50. Evans, E., and W. Rawicz. 1990. Entropy-driven tension and bending elasticity in condensed-fluid membranes. Phys. Rev. Lett. 64:2094-2097.
51. Olbrich, K., W. Rawicz, D. Needham, and E. Evans. 2000. Water permeability and mechanical strength of polyunsaturated lipid bilayers. Biophys. J. 79:321-327.
52. Rawicz, W., K. C. Olbrich, T. McIntosh, D. Needham, and E. Evans. 2000. Effect of chain length and unsaturation on elasticity of lipid bilayers. Biophys. J. 79:328-339.
53. Lemaire-Ewing, S., C. Prunet, T. Montange, A. Vejux, A. Berthier, G. Bessède, L. Corcos, P. Gambert, D. Néel, and G. Lizard. 2005. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol. Toxicol. 21:97-114.
54. Simon, S. A., T. J. McIntosh, A. D. Magid, and D. Needham. 1992. Modulation of the interbilayer hydration pressure by the addition of dipoles at the hydrocarbon/water interface. Biophys. J. 61:786-799.
55. Smondyrev, A. M., and M. L. Berkowitz. 2001. Effects of oxygenated sterol on phospholipid bilayer properties: a molecular dynamics simulation. Chem. Phys. Lipids. 112:31-39.
56. Phillips, J. E., Y.-J. Geng, and R. P. Mason. 2001. 7-Ketocholesterol forms crystalline domains in model membranes and murine aortic smooth muscle cells. Atherosclerosis. 159:125-135.
57. Rooney, M., W. Tamura-Lis, L. J. Lis, S. Yachnin, O. Kucuk, and J. W. Kauffman. 1986. The influence of oxygenated sterol compounds on dipalmitoylphosphatidylcholine bilayer structure and packing. Chem. Phys. Lipids. 41:81-92.
58. Zhou, Y., and R. M. Raphael. 2005. Effect of salicylate on the elasticity, bending stiffness, and strength of SOPC membranes. Biophys. J. 89:1789-1801.
59. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta. 1462:55-70.
60. White, S. H., and W. C. Wimley. 1994. Peptides in lipid bilayers: structural and thermodynamical basis for partitioning and folding. Curr. Opin. Struct. Biol. 4:79-86.
61. Coles, M., W. Bicknell, A. A. Watson, D. P. Fairlie, and D. J. Craik. 1998. Solution structure of amyloid β-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry. 37:11064-11077.
62. Crescenzi, O., S. Tomaselli, R. Guerrini, S. Salvadori, A. M. D'Ursi, P. A. Temussi, and D. Picone. 2002. Solution structure of the Alzheimer amyloid β-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. Eur. J. Biochem. 269:5642-5648.
63. Mason, R. P., W. J. Shoemaker, L. Shajenko, and T. E. Chambers. 1992. Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol. Neurobiol. Aging. 13:413-419.
64. Geddes, D. M., R. S. Cargill II, and M. C. LaPlaca. 2003. Mechanical stretch to neurons results in a strain rate and magnitude-dependent increase in plasma membrane permeability. J. Neurotrauma. 20:1039-1049.
65. Avdulov, N. A., S. V. Chochina, U. Igbavboa, E. O. O'Hare, F. Schroeder, J. P. Cleary, and W. G. Wood. 1997. Amyloid β-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes. J. Neurochem. 68:2086-2091.
66. Nelson, T. J., and D. L. Alkon. 2005. Oxidation of cholesterol by amyloid precursor protein and β-amyloid peptide. J. Biol. Chem. 280:7377-7387.
67. Svennerholm, L., and C.-G. Gottfries. 1994. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62:1039-1047.